Fate Therapeutics
FATE
#6664
Rank
A$0.68 B
Marketcap
$6.00
Share price
3.09%
Change (1 day)
66.21%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -$3.28

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.25. In 2022 the company made an earnings per share (EPS) of -$4.36 a decrease over its 2021 EPS that were of -$3.34.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.28-24.77%
2022-$4.3630.49%
2021-$3.347.21%
2020-$3.1245.45%
2019-$2.1419.17%
2018-$1.8017.65%
2017-$1.53-3.77%
2016-$1.59-12.4%
2015-$1.81-3.97%
2014-$1.89-2.09%
2013-$1.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$11.74 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.32-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$12.97 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.65 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.94-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA